Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ramat Gan, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
Silexion Therapeutics Corp has filed 263 SEC EDGAR filings since 09 May 2024

SEC filing history

Showing 126-150 of 263 matching filings.

Per page
25
Current page
6
DEF 14A File 001-42253

DEF 14A

Filing date
31 Jul 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-42253

PRE 14A

Filing date
21 Jul 2025
Reporting date
21 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-42253

DEFA 14A

Filing date
07 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-94600

SCHEDULE 13D/A filing

Filing date
26 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-42253

DEFA 14A

Filing date
23 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-42253

DEF 14A

Filing date
16 Jun 2025
Reporting date
16 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-42253

PRE 14A

Filing date
05 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-282017

EFFECT filing

Filing date
29 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-282017

POS AM

Filing date
28 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-282556

424B3

Filing date
13 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-282932

424B3

Filing date
13 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .